DR. STEPHEN L. DICKSON JR., MD

Plain English
This study looked at changes in the hippocampus, a brain region important for memory, in people with early Alzheimer's disease (AD) to see if it can indicate how effective treatments might be. They found that a larger hippocampal volume is associated with better cognitive performance and that a decrease in volume corresponds with worsening memory over time. Specifically, preserving at least 40 cubic millimeters of hippocampal volume over 18 months is linked to noticeable cognitive benefits from treatments, which could involve data from over 23,000 people across thirty years. Who this helps: This information benefits patients with early Alzheimer's and their doctors.

Plain English
This research reviewed how effective and safe benzodiazepines are for adults experiencing moderate-to-severe alcohol withdrawal in hospitals. Out of 603 articles examined, only 24 provided useful data, showing a variety of results and safety concerns including the need for intubation, seizures, and ICU care. The inconsistent findings indicate a need for more rigorous studies to better guide treatment in these situations. Who this helps: This helps patients undergoing alcohol withdrawal in hospitals and the doctors treating them.

Plain English
This study looked at how to deal with participants in clinical trials who have data from the start but none after they begin treatment. The researchers tested different methods to get a clear picture of how treatments work, even when some data is missing. They found that certain analysis methods, which used initial data effectively, helped produce valid results, indicating that the way we handle missing data can significantly impact our understanding of treatment effects. Who this helps: This research benefits doctors and researchers by improving the accuracy of clinical trial results.

Plain English
This study looked at the challenges faced by primary care doctors in detecting and managing early Alzheimer's disease. It found that there are significant obstacles that prevent these healthcare providers from taking on a larger role, which is crucial as treatments for Alzheimer's are improving. The authors suggest that changes are needed in the U.S. healthcare system to better support patients and help doctors provide the necessary care for those with early Alzheimer's. Who this helps: This helps patients with early Alzheimer's disease and their primary care doctors.

Plain English
This study looked at whether using a mix of reusable and single-use catheters (called Mixed-use) is as effective and more cost-efficient compared to using only single-use catheters for bladder drainage. Researchers found that Mixed-use saved an average of £1,348.82 annually per patient and participants needed significantly fewer single-use catheters—902 less per year on average—while having similar health outcomes. These results highlight that the Mixed-use approach is not only cheaper but could also help reduce environmental waste. Who this helps: This benefits patients who need catheters and healthcare systems looking to lower costs.

Plain English
This study looked at whether using a mix of reusable and single-use catheters is as safe as using only single-use catheters for people who need to empty their bladders regularly. In a trial with 578 participants, 28.7% of those using mixed catheters had a urinary tract infection (UTI) compared to 34.4% using only single-use catheters, showing that mixed-use is just as safe. Additionally, those in the mixed-use group used 35% fewer antibiotics than those using single-use catheters, which is significant for reducing medication use. Who this helps: This benefits patients who use intermittent catheters for bladder management.

Plain English
This study looked at how to improve the quality and safety of healthcare by exploring a new leadership approach called Systems Leadership. Researchers found that traditional top-down methods have not been effective for over 30 years in addressing issues like inappropriate and harmful care. They recommend that leaders adopt a more collaborative style, encouraging shared responsibility across all levels of the healthcare system to make real changes. Who this helps: This helps patients by promoting safer and more effective healthcare practices.

Plain English
This study looked at how an opioid use disorder (OUD) consult service impacted the success of patients being recommended for post-hospital care. Among 381 patients, those who received an OUD consult had a referral success rate of 49.3%, while the non-consult group's rate was slightly higher at 55.2%. Although the consult helped more patients start medication for OUD and receive naloxone before leaving the hospital, it did not increase the chances of successfully transitioning to post-acute care. Who this helps: This research benefits patients with opioid use disorder and healthcare providers working to improve care transitions.

Plain English
The Ensembl project released a record 1,927 new genomes this year, bringing the total to 37,546 genomes available for research. They improved tools for exploring how genes are regulated and are transitioning to a new platform for future updates. This advancement matters because it makes it easier for scientists to study genetic information across many species, leading to better understanding of biology and medicine. Who this helps: This benefits researchers and scientists studying genetics and evolution.

Plain English
This study looked at how much clinicians know about nonpharmaceutical fentanyl (NPF), a powerful drug linked to many overdose deaths, and how they approach overdose prevention. Out of 136 clinicians surveyed, most knew how strong NPF is and believed that preventing overdoses is very important. However, only 21% felt very familiar with prevention strategies, and use of these strategies varied widely—only 7% frequently provided fentanyl test kits, while 70% often prescribed naloxone, a medication that can reverse overdoses. Who this helps: This information can benefit patients at risk of opioid overdoses and support their doctors in providing better care.

Plain English
This study looked at how older adults in England feel about stylish grab rails installed in their homes to help them stay independent as they age. Researchers interviewed 33 participants, averaging 64 years old, and found that many appreciated the grab rails for their attractive design, which made them feel less stigmatized about having mobility issues. However, some participants were unsure about the grab rails' functionality or their connection to a large energy company. Who this helps: This benefits older adults who want to maintain their independence and feel comfortable in their homes.

Plain English
This study looked at psilocybin dispensaries in Canada, focusing on where they are located and the health claims made on their websites. As of May 2024, researchers found 57 dispensaries in 15 cities, with 2.6% of Canadians living within a kilometer of one. Many dispensaries claimed mental health benefits from psilocybin, but they often failed to provide important safety warnings about potential risks like using it while driving or during pregnancy. Who this helps: This research benefits patients and consumers considering psilocybin for mental health treatment.

Plain English
Researchers at MD Anderson Cancer Center studied how cryoprecipitate, a blood product rich in fibrinogen, is used to manage low fibrinogen levels in children and young adults with leukemia. They found that cryoprecipitate effectively increased fibrinogen levels from a median of 85.5 mg/dL before treatment to 185 mg/dL afterward, with 75% of patients receiving it for bleeding prevention. This is important because it shows that cryoprecipitate can help reduce bleeding risks in vulnerable patients with leukemia, despite the need for more studies to confirm its full benefits. Who this helps: This helps pediatric leukemia patients and their doctors.

Plain English
This study looked at how far-ultraviolet (Far-UVC) light affects human lung cells and tissues. Researchers found that even low doses of Far-UVC light (from 206 nm and 222 nm) can damage DNA in lung cells and lead to their death. Specifically, they observed that after exposure, lung cells showed signs of DNA damage and reduced survival rates, along with increased release of a substance indicating cell injury. Who this helps: This benefits patients with lung infections and doctors treating them, as it provides important safety information about a potential treatment method.

Plain English
This study looked at how a new non-invasive treatment that stimulates gamma oscillations in the brain affects people with mild to moderate Alzheimer's disease. After 6 months, participants receiving this treatment saved about 4.83 months in their ability to perform daily activities, 4.59 months in cognitive function, and 4.09 months in brain volume loss compared to those who did not receive the treatment. These results suggest that the treatment may help slow down the progression of Alzheimer's symptoms, which is important for improving patients' quality of life. Who this helps: This helps patients with Alzheimer's disease and their caregivers.

Plain English
This study evaluated the implementation and effectiveness of two types of speech therapy for people with Parkinson's who struggle with speaking clearly. Researchers looked at 388 participants and found that the Lee Silverman Voice Treatment (LSVT) was delivered more consistently and at a higher intensity than the Standard NHS Speech and Language Therapy, which included a wider range of techniques but with less focus on speaking skills. This matters because it highlights the need for better service coordination and tailored approaches to speech therapy, ensuring patients receive the most effective treatment for their communication challenges. Who this helps: This helps patients with Parkinson's who need effective speech therapy options.

Plain English
This study looked at the effects of a drug called valiltramiprosate on people with early Alzheimer's disease who have a specific genetic risk factor (the APOEε4/ε4 allele). While the drug did not show significant improvement in cognitive tests compared to a placebo, it did slow brain shrinkage by 18% after 78 weeks. This is important because it suggests that the drug might help preserve brain health even if it doesn't noticeably improve daily cognitive function right away. Who this helps: This research benefits patients with mild cognitive impairment and early Alzheimer's disease, especially those with the APOEε4/ε4 genetic variation.

Plain English
This research looked at a two-week training program for medical trainees focused on caring for patients with opioid use disorder (OUD). The study found that after completing the program, 80% of trainees felt they received adequate training, 96% felt prepared to diagnose OUD, and 92% were ready to treat it. This training helps reduce stigma around patients who use drugs and builds the confidence of future healthcare providers in managing OUD effectively. Who this helps: This benefits doctors and medical trainees, ultimately improving care for patients with opioid use disorder.

Plain English
This paper examines how prescription drug prices are determined in the United States, highlighting the various benchmarks used to set these prices. It explains that these benchmarks influence how much pharmacies get paid for medications and how much patients owe. Understanding these pricing standards is crucial because drugs can cost different amounts depending on the insurance program; for example, the same drug may have a different price for Medicare compared to Medicaid. Who this helps: This information benefits patients, pharmacies, and healthcare providers navigating drug costs.

Plain English
This research studied a new treatment called REM127 for people with mild to moderate Alzheimer's disease. In a small trial with 14 participants, it was found that while the treatment improved some brain markers related to the disease, it also caused liver problems that led to stopping the study early. The findings suggest that REM127 might help with Alzheimer's symptoms and brain function, but more research is needed to find a safer version of this treatment. Who this helps: This benefits patients with Alzheimer's disease and their families.

Plain English
This study explored a new method using a special gel to improve MRI images of the vagina for women undergoing radiation therapy for cancer. Researchers found that using just 10-15 cc of this gel during the MRI enhanced the visibility of key areas like the vaginal vault and cervix, leading to better imaging quality compared to older methods. This improvement is important because clearer images help doctors plan more effective treatments for their patients. Who this helps: This benefits patients with gynaecological cancers undergoing radiation therapy.

Plain English
This study looked at how often people with commercial insurance used HIV prevention medication called PrEP from 2019 to 2021. It found that most prescriptions were for more expensive branded versions of the drug, even though a generic version was available that could save insurers 33% in costs without a significant difference in effectiveness. Understanding these trends is important because it highlights opportunities to reduce healthcare spending while still providing effective prevention options. Who this helps: This benefits patients and insurance companies by potentially lowering costs while maintaining access to effective HIV prevention.

Plain English
The study created and tested a new tool called the Spinocerebellar Ataxia Composite Scale (SCACOMS) to measure how spinocerebellar ataxia (SCA) progresses and how well treatments work. By examining data from multiple patient groups, the researchers found that SCACOMS could more accurately detect changes in patients' condition than previous methods. This is important because it allows doctors to better assess the impact of new treatments and monitor disease progression in SCA patients. Who this helps: This helps patients with spinocerebellar ataxia and their doctors.

Plain English
This study looked at how improving the treatment of anorexia nervosa (AN) for adults in England, Germany, and Spain could save money and improve health outcomes. It found that using enhanced care pathways, like cutting wait times for outpatient services and providing specialized treatment after a referral, could result in significant financial benefits—up to €259,909 per patient in Germany and more than a 50% reduction in healthcare costs overall. This matters because it shows that investing in better initial care can not only help patients recover more effectively but also lighten the financial burden on healthcare systems. Who this helps: This helps patients suffering from anorexia nervosa and the healthcare providers who care for them.

Plain English
This study looked at how the internal clock of legume plants affects their ability to form beneficial relationships with nitrogen-fixing bacteria called rhizobia. Researchers found that changes in the plant’s circadian clock led to worse growth and fewer nodules where rhizobia live; specifically, legumes like Medicago and soybean showed compromised nodulation and reduced growth. Understanding this timing is crucial because it can help improve how legumes and rhizobia work together, potentially boosting agricultural productivity. Who this helps: This helps farmers and agricultural scientists working to improve crop yields.

Plain English
This study looked at where cannabis stores are located in Canadian cities four years after cannabis became legal. It found that 86% of cities have areas with a high concentration of cannabis stores, with some neighborhoods in Toronto having as many as 25 stores close together. The research showed that poorer neighborhoods tend to have more cannabis shops, especially in private markets, meaning that access to cannabis is greater in those areas. Who this helps: This information is valuable for city planners and policymakers aiming to manage cannabis store locations better, especially for communities affected by concentration in lower-income areas.

Plain English
This study compared the effectiveness of two speech therapy methods—Lee Silverman voice treatment (LSVT LOUD) and standard NHS speech therapy—against not receiving any therapy for people with Parkinson's disease who have difficulty speaking. Researchers found that those who received LSVT LOUD reported significantly fewer problems with their voice after three months, scoring 8 points lower compared to those who had no therapy and 9.6 points lower than those who received NHS therapy. The results highlight that LSVT LOUD is the better option for improving voice quality in this patient group, as NHS therapy did not show any advantage. Who this helps: Patients with Parkinson's disease struggling with speech problems.

Plain English
This study looked at the use of a drug called venetoclax in 11 children and teenagers who were newly diagnosed with acute myeloid leukemia (AML). Most of these patients responded well to the treatment, with many achieving complete remission early on, and they experienced side effects similar to other standard AML treatments without having to stop the drug due to toxicity. This matters because it shows that venetoclax could be a promising option for treating AML in young patients, highlighting the need for more research to confirm its long-term benefits. Who this helps: Patients with acute myeloid leukemia and their doctors.

Plain English
This research paper looks at a type of childhood leukemia that is influenced by certain gene expressions. Researchers found that menin inhibitors can effectively treat specific types of pediatric acute leukemia, particularly those linked to KMT2A and NPM1 mutations. By blocking the interaction between menin and these genes, these inhibitors may help cells develop normally instead of causing leukemia, showing great promise for treatment. Who this helps: This benefits children and adolescents with specific types of leukemia, as well as the doctors treating them.

Plain English
This study examined how two different speech therapy methods affect speech problems in people with Parkinson's disease. It involved 388 participants, and results showed that those who underwent the Lee Silverman Voice Treatment LOUD experienced a significant reduction in the impact of their voice problems after three months compared to those who received no therapy (an improvement score of -8.0). However, the National Health Service speech therapy did not show significant benefits in comparison to the control group. Who this helps: This research helps patients with Parkinson's disease who have speech difficulties, as well as their healthcare providers.

Plain English
The MultICath Trial studied the safety and acceptability of using both multi-use and single-use catheters for people who need intermittent catheterization, with 578 participants taking part over a 12-month period. The trial aimed to find out if using reusable catheters (if cleaned properly) is just as safe as using single-use catheters. This is important because it could reduce plastic waste and ensure that patients always have access to catheters. Who this helps: Patients who require intermittent catheterization.

Plain English
This study looked at how anxiety influences food choices in people with anorexia nervosa, a serious eating disorder where individuals limit their food intake and avoid high-calorie foods. Researchers found that anxiety plays a key role in driving these behaviors, as certain brain circuits associated with fear and stress get activated, leading to a shift from wanting food to avoiding it. Understanding this connection is important because it can help develop better treatments that target anxiety and improve eating behaviors. Who this helps: This benefits patients with anorexia nervosa and their doctors.

Plain English
This study looked at how to get permission for health research involving Indigenous children in a way that respects their culture and community. Researchers reviewed nearly 3,000 articles but found only 11 that focused on effective methods of consent from parents and children in Indigenous settings. They highlighted the importance of involving families and communities in the consent process, recommending that consent should happen together, on the land, and with community input. Who this helps: Indigenous children and their families benefit from more equitable access to health research and services.

Plain English
This study looked at how a natural compound called Apigenin can help make antiretroviral drugs more effective against cells infected with HTLV-1, a virus that causes a serious neurological disease. Researchers found that when Apigenin is used alongside antiretroviral drugs like Lopinavir and Zidovudine, it significantly increases the death of these infected cells. Specifically, the combination treatment caused a major increase in cell death rates, indicating that Apigenin enhances the effectiveness of existing medications. Who this helps: This benefits patients suffering from HTLV-1-related diseases by improving their treatment options.

Plain English
This study focused on prostate cancer treatment, specifically looking at a new method called virtual high-dose-rate brachytherapy boost (vHDRB), which aims to deliver a higher dose of radiation using non-invasive techniques. Researchers found that traditional brachytherapy is effective, but its use is declining despite clear benefits in cancer outcomes, and vHDRB could offer a modern alternative by mimicking these higher doses without the need for invasive procedures. This is important because improving treatment options can lead to better outcomes for patients with prostate cancer. Who this helps: This helps patients with prostate cancer and their doctors by providing new treatment options.

Plain English
This study looked at how far people in different racial groups have to drive to reach health care facilities across the United States. It found that in many places, Black residents often live farther from the nearest health care facility than White residents, especially in the Southeast. For example, some areas in this region show significant access issues, which could worsen health inequalities. This is important because it highlights the need for better planning to improve access to health care based on where people live. Who this helps: This helps patients, especially those in underserved Black communities.

Plain English
This study looked at 33 hospitalized patients who have opioid use disorder and were also experiencing pain. Researchers found that 90.9% of participants successfully transitioned from low dose intravenous buprenorphine to sublingual buprenorphine-naloxone without significant withdrawal or increased pain, as indicated by stable pain and withdrawal scores throughout their treatment. This is important because it shows that starting treatment with buprenorphine in the hospital can effectively help patients manage both their opioid dependence and pain. Who this helps: This helps patients with opioid use disorder and chronic pain.

Plain English
This study looked at how the distance to healthcare facilities affected death rates from COVID-19 after vaccines became available. The researchers found that people living farther away from these facilities were more likely to die from COVID-19, especially in areas with more Black and Hispanic residents. This is important because it highlights the need for better access to healthcare services to reduce illness and death in underserved communities. Who this helps: This helps patients, especially those in racially and ethnically diverse communities.

Plain English
This study looked at the prices of insulin in the U.S. between 2012 and 2019, focusing on both the listed prices and the actual prices paid after discounts. It found that the prices of long-acting insulin rose by nearly 24% each year from 2012 to 2014, but dropped by around 8% annually after new products were introduced in 2015. Similarly, short-acting insulin prices increased by 5.6% before falling after new options became available, while human insulin prices kept rising steadily without new entries. This matters because it shows how competition from new insulin products can lead to lower prices for patients, despite initial price hikes. Who this helps: Patients needing insulin treatment.

Plain English
This study examined how the Omicron variant of COVID-19 spreads in Tamilnadu, India, using a special mathematical model that includes factors like vaccination and quarantine. The researchers found that their model could help predict whether the outbreak would continue to grow based on real pandemic data. Understanding this spread is important for making decisions about public health measures to keep the population safe. Who this helps: This helps public health officials make informed decisions during outbreaks.

Plain English
This study looked at how Medicare's ability to negotiate drug prices starting in 2026 will affect costs for certain high-cost medications. Researchers found that for four of the ten drugs expected to be negotiated, the minimum discount set by law will save a combined total of $1.8 billion, with discounts of 60% for etanercept and between 25% for several cancer drugs. However, to reach total estimated savings of $3.7 billion predicted by the Congressional Budget Office, prices for most negotiated drugs will need to drop below their current levels. Who this helps: This benefits patients who rely on these medications and may face lower out-of-pocket costs.

Plain English
This study looked at how the arrival of new pharmaceutical treatments affected the prices of existing drugs between 2011 and 2019. Researchers found that when new competitors were introduced, the net prices of older drugs grew 4.2% more slowly, leading to a total savings of $10.4 billion or an 18.5% reduction in spending on these treatments. This is important because it shows that new drug options can effectively lower costs for patients and healthcare systems, even if the list prices of drugs keep rising. Who this helps: Patients and healthcare providers benefit from reduced drug costs.

Plain English
This study looked at how current guidelines for performing cardiopulmonary resuscitation (CPR) often don’t fit well in places with fewer resources, like many low-income countries. The researchers gathered experts from various countries to agree on a new approach, identifying gaps in CPR practices and proposing ways to improve care. This is important because making CPR guidelines more relevant can save more lives in these settings. Who this helps: This helps patients and health care providers in low-resource areas.

Plain English
This study looked at how much money people could save on prescription drugs through minimum discounts set by the Inflation Reduction Act. The findings showed that these minimum discounts could significantly lower drug prices, helping families save an average of $1,000 or more per year. This is important because it can make necessary medications more affordable for many people, improving their health and financial well-being. Who this helps: Patients needing affordable access to medications.

Plain English
This study looked at how many Medicare Part D claims were eligible for discounts through the 340B program from 2013 to 2020. Researchers found that the share of prescriptions written by doctors affiliated with 340B increased from 9.4% to 19.3%, and the number of these prescriptions filled at 340B pharmacies grew from 18.4% to nearly 50%. Overall, the proportion of claims benefiting from 340B discounts rose from 1.7% to 9.6%, but by 2020, only about half of eligible prescriptions were filled at 340B pharmacies. Who this helps: This information benefits patients who rely on affordable medications through the 340B program.